News & Press Releases

Marc Mantell was quoted in an article by The American Lawyer examining the M&A market's strong first half of 2026, particularly for mega deals, and the factors that could shape deal activity through the remainder of the year.

Law.com featured Sige Gutman in a Q&A about his career and how it led him to become the Chair of Mintz’s Life Sciences Litigation Practice. In the profile, Sige discusses how he discovered his fondness for life sciences patent law, his path toward leadership, and advice for others on how to effectively lead while balancing a sophisticated legal practice.

Jacob Hupart, Arameh O'Boyle, and Will McKitterick authored a Law360 article examining a recent decision that dismissed a proposed greenwashing lawsuit challenging Apple's carbon neutrality claims. The article explores the implications of the ruling and the lessons it offers companies making environmental and sustainability-related representations.

Elissa Flynn-Poppey and Edmund Daley were recognized with a ‘shout-out’ for Litigator of the Week by The American Lawyer’s Litigation Daily for securing a significant victory before the Massachusetts Supreme Judicial Court. The court ruled that a proposed statewide rent control ballot initiative could not appear on the ballot because it would have impermissibly considered religion in determining whether a property was subject to rent control under the Massachusetts Constitution.

Elissa Flynn-Poppey and Edmund Daley were featured in a Law.com article about a significant victory they secured before the Massachusetts Supreme Judicial Court, which ruled that a proposed statewide rent control ballot initiative could not appear on the November ballot. The court held that the measure violated Article 48 of the Massachusetts Constitution because it made religion a factor in the law’s application by including an exemption for facilities that are operated solely for religious purposes.

Theresa Carnegie was quoted in a Law360 Healthcare Authority article examining the growing wave of state-level regulation targeting pharmacy benefit managers, as lawmakers expand oversight in response to concerns about pricing, market consolidation, and industry practices.